Table 1 Patient and tumour characteristics of the study population
All patients, n = 106 | Patients with low TILs, n = 81 | Patients with intermediate TILs, n = 25 | |||||
|---|---|---|---|---|---|---|---|
Characteristic | n | % (col) | n | % (col) | n | % (col) | p1 |
Age (years) | 0.12 | ||||||
60–69 | 44 | (41) | 44 | (54) | 18 | (72) | |
70–89 | 62 | (59) | 37 | (46) | 7 | (28) | |
Tumour size (mm)2 | 0.32 | ||||||
< 20 | 46 | (43) | 33 | (41) | 13 | (52) | |
≥ 20 | 60 | (57) | 48 | (59) | 12 | (48) | |
Histological subtype | 0.40 | ||||||
Ductal | 76 | (72) | 56 | (70) | 19 | (76) | |
Lobular | 12 | (11) | 11 | (14) | 1 | (4) | |
Other invasive3 | 17 | (16) | 13 | (16) | 5 | (20) | |
Unknown | 1 | (1) | 1 | (1) | 0 | ||
Malignancy grade4 | 0.96 | ||||||
1 | 37 | (43) | 28 | (42) | 9 | (45) | |
2 | 45 | (52) | 35 | (52) | 10 | (50) | |
3 | 5 | (6) | 4 | (6) | 1 | (5) | |
Axillary node status | 0.08 | ||||||
Negative | 58 | (55) | 41 | (51) | 17 | (68) | |
Positive | 47 | (44) | 40 | (49) | 7 | (28) | |
Unknown | 1 | (1) | 0 | 1 | (4) | ||
Oestrogen receptor status (%) | 0.18 | ||||||
10–99 | 20 | (19) | 13 | (16) | 7 | (28) | |
100 | 86 | (81) | 68 | (84) | 18 | (72) | |
Progesterone receptor status (%) | 0.20 | ||||||
10–99 | 75 | (71) | 57 | (70) | 18 | (72) | |
100 | 29 | (27) | 22 | (27) | 7 | (28) | |
Unknown | 2 | (2) | 2 | (3) | 0 | (0) | |
Ki67 index (%) | 0.02 | ||||||
< 14 | 72 | (68) | 60 | (74) | 12 | (48) | |
≥ 14 | 32 | (30) | 20 | (25) | 12 | (48) | |
Unknown | 2 | (2) | 1 | (1) | 1 | (4) | |